Differences

This shows you the differences between two versions of the page.

--- documentation:oncology:meeting_notes_2019_mar-12 [2019/03/13 12:03] – created mgurley
+++ documentation:oncology:meeting_notes_2019_mar-12 [2019/03/13 13:38] (current) – mgurley
@@ Line 1: / Line 1: @@
 **Participants**
-Christian Reich, Rimma Belankaya, Dmytry Dymshyts, Andrew Williams,Robert Miller
+Christian Reich, Rimma Belankaya, Dmytry Dymshyts, Andrew Williams, Robert Miller, Michael Gurley
 **Topics**
-{{:documentation:oncology:oncology_wg_f-t-f_2018-05-02.pptx|Outline}}
+  * Reviewed Dmytry's latest progress on the NAACCR ingestion script.
-  * Detailed planning of vocabulary tasks
+    * Discussed the possibility of moving NAACCR schemas into a new structure to keep the CONCEPT.concept_code clean (not contain anything NOT in NAACCR source data).  But we decided for version 1 we would include NAACCR schemas in the vocabulary, and include NAACCR schema IDs in site-dependent NAACCR items and NAACCR Item Codes.  This means that ETL developers will have to know to use Rimma's ETL code to map NAACCR data into OMOP.
-  * Comprehensive review of Cancer Registry and integration of NAACCR into OMOP vocabulary
+    * Agreed that mapping NAACCR schemas to ICD site/histology combinations is a must have for version 1 of NAACCR ingestion.  Rimma's ETL SQL will not work without it.
-  * Priorities and use cases
+    * Discussed whether NAACCR site-dependent variables should be duplicated across schemas.  Dmytry's first version of NAACCR ingestion is duplicating them.  We agreed that they should not.  Dmytry said he can dedupe them.
+    * Resolved "Curate NAACCR Items/Item Codes and OMOP domains":  [[https://github.com/OHDSI/OncologyWG/issues/26]]
+    * Resolved "How should we handle long CONCEPT.concept_name entries that exceed 255 characters coming from NAACCR?": [[https://github.com/OHDSI/OncologyWG/issues/28]]
+    * Discussed: How should we handle 'Numeric' NAACCR items that define numeric ranges?:https://github.com/OHDSI/OncologyWG/issues/26
+    * Resolved "How should we handle NAACCR provenance concepts?": [[https://github.com/OHDSI/OncologyWG/issues/32]]
+    * Discussed 'How should we handle versions of staging variables?  For both TNM and AJCC variables?': [[https://github.com/OHDSI/OncologyWG/issues/31]]
+    * Resolved "Should we record dates as a separate measurement record.(e.g. Date regional lymph node dissection NAACCR #682)?":https://github.com/OHDSI/OncologyWG/issues/33
+    * Resolved "How do we handle different versions of NAACCR?": [[https://github.com/OHDSI/OncologyWG/issues/34]]
-**Decisions and next steps**
-  - Submit Diagnosis and Treatment Proposal to the CDM Workgroup
-  - [[https://docs.google.com/spreadsheets/d/14Gmkypv15scPma-FmyDsxN3CDiRokAj7KaZk_-94xj0/edit?usp=sharing|Detailed Vocabulary Tasks]]
-  - Collect community use cases here: [[http://forums.ohdsi.org/t/oncology-data-use-cases/4382|oncology-data-use-cases]]